700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
School of Pharmacy
University of North Carolina
Dr. Ming received his early training at the B.S and M.S. levels from China Pharmaceutical University and The University of Texas College of Pharmacy. In 2004 Xin began his PhD studies at The University of North Carolina School of Pharmacy. His thesis work with Prof. Dhiren Thakker dealt with mechanisms of transporter-mediated drug delivery. In 2008 Dr. Ming joined Prof. Rudy Juliano′s laboratory as a postdoctoral fellow to work on projects concerning targeted delivery of antisense and siRNA oligonucleotides and the underlying cell and molecular mechanisms. In 2011, he was appointed a Research Assistant Professor in the same university. Since then, he has extended his research to targeted delivery of oligonucleotide-based therapeutics for chronic kidney diseases and diabetes.
Transporter-targeted drug delivery for tumors and kidney diseases treatment, Targeted delivery of oligonucleotide-based therapeutics for tumors, chronic kidney diseases and diabetes.
Global Speakers in the subject
Global Experts in the subject